Article
[The efficacy and prognostic predictors of different treatment courses with pegylated interferon α-2a and ribavirin combination in recurrent chronic hepatitis C patients].
Zhonghua nei ke za zhi - 1 Aug 2015
Rao Huiying, Yang Ruifeng, Shang Jia, Xu Xiaoyuan, Chen Xinyue, Dou Xiaoguang, Feng Yinong, Gao Zhiliang, Xie Qing, Li Jun, You Hong, Chen Guofeng, Niu Junqi, Gong Guozhong, Hou Jinlin, Chen Hong, Zhang Dazhi, Wei Lai
Abstract excerpt
OBJECTIVE: To study the efficacy and outcome predictors of combined re-treatment with pegylated interferon (Peg-IFN) α-2a and ribavirin in recurrent chronic hepatitis C (CHC) patients. METHODS: A multicenter, prospective, randomized trial was designed. A total of 125 recurrent CHC patients were recruited in 16 clinical centers and randomly assigned into two groups: one was Peg-IFNα-2a combined with ribavirin for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.